MedPath

Randomised trial of carbetocin versus oxytocin for the prevention of postpartum haemorrhage after caesarean section - LOXY Trial

Phase 1
Conditions
Postpartum haemorrhage after caesarean section
Registration Number
EUCTR2005-002812-94-GB
Lead Sponsor
orth Bristol NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
380
Inclusion Criteria

Women undergoing elective or emergency caesarean section after 37 weeks of pregnancy.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Women with multiple gestation, placenta praevia and placental abruption.

Women undergoing caesarean section with general anaesthesia.

Women with caesarean section at less than 37 weeks.

Women having emergency caesarean section for fetal or maternal distress.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath